Table 1:
Baseline patient characteristics for unmatched and matched patient cohorts.
| Variable | Unweighted patient cohort | Weighted patient cohort | ||||
|---|---|---|---|---|---|---|
| Salvage focal cryotherapy, n=72, (%) | Salvage whole gland cryotherapy, n=313, (%) | p-value | Salvage focal cryotherapy (%) | Salvage whole gland cryotherapy (%) | p-value | |
| Age, years | ||||||
| <60 | 8 (11.1) | 27 (8.6) | 0.03 | 15.3 | 8.2 | 0.37 |
| 61-70 | 23 (31.9) | 140 (44.7) | 32.0 | 44.1 | ||
| 71-80 | 41 (56.9) | 146 (46.7) | 52.6 | 47.6 | ||
| PSA, ng/mL | ||||||
| ≤1 | 2 (2.8) | 6 (1.9) | <0.01 | 2.9 | 2.0 | 0.45 |
| 1-1.99 | 12 (16.7) | 37 (11.8) | 16.2 | 11.8 | ||
| 2-4.99 | 32 (44.4) | 168 (53.7) | 43.2 | 53.9 | ||
| 5-9.99 | 26 (36.1) | 102 (32.6) | 37.7 | 32.2 | ||
| Unknown | 0 (0) | 14 (3.72) | ||||
| Gleason Score | ||||||
| ≤6 (%) | 31 (45.6) | 107 (34.2) | 0.46 | 36.9 | 35.4 | 0.73 |
| 7 (%) | 26 (38.2) | 108 (34.5) | 38.0 | 34.6 | ||
| ≥ 8 (%) | 5 (7.4) | 84 (26.8) | 16.6 | 25.9 | ||
| Unknown (%) | 6 (8.8) | 14 (4.5) | 8.5 | 4.1 | ||
| ADT | ||||||
| Yes (%) | 19 (26.4) | 98 (31.3) | 0.85 | 29.0 | 30.4 | 0.18 |
| No (%) | 52 (72.2) | 209 (66.8) | 69.2 | 67.8 | ||
| Unknown (%) | 1 (1.4) | 6 (1.9) | 1.8 | 1.8 | ||
PSA: Prostate Specific Antigen; ADT: Androgen Deprivation Therapy